| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/28/2001 | US6280772 Composition for slow release of active carboxy compound and polester of hydroxy acid, cooling and complexing |
| 08/28/2001 | US6280771 For controlled drug delivery |
| 08/28/2001 | US6280770 Microemulsions as solid dosage forms for oral administration |
| 08/28/2001 | US6280769 Breath freshening comestible product |
| 08/28/2001 | US6280767 Easy to twist open with the fingers, and is suitable for encapsulating, for example, pharmaceuticals, cosmetics, and food |
| 08/28/2001 | US6280766 Administering transdermal therapeutic systems comprising active substance in to ensure a blood plasma concentration of active substance which is approximately constant over a useful application period for therapy of pain, drug abuse |
| 08/28/2001 | US6280765 Controlled-delivery system containing an anhydrous polymer matrix in which is dispersed an oil in the form of droplets |
| 08/28/2001 | US6280764 Patch for therapy of acne |
| 08/28/2001 | US6280763 Apparatus and method for transdermal delivery of bupropion |
| 08/28/2001 | US6280762 Center filled confectionery |
| 08/28/2001 | US6280761 Nicotine lozenge |
| 08/28/2001 | US6280759 Method of controlled release and controlled release microstructures |
| 08/28/2001 | US6280752 For use in cosmetics and drugs |
| 08/28/2001 | US6280751 For treatment of disease or physical disability or sports injuries, for build up and maintenance of immune system, or for protection against disease or pollution |
| 08/28/2001 | US6280745 Pharmaceutical aqueous-gel composition comprising constitutive polymer selected from polyoxyalkylene block copolymers and/or polyethers, modifier polymer selected from cellulose ethers, sodium carboxymethylcellulose and polyacrylates, soap |
| 08/28/2001 | US6280744 Pharmaceutical composition which comprises pharmaceutical active agent and inorganic aerogel particles |
| 08/28/2001 | US6280729 Treating christmas disease in patient by administering effective amount of therapeutic composition comprising storage stable aqueous solution of purified factor ix |
| 08/28/2001 | US6280717 Cation exchange resin preparation |
| 08/28/2001 | US6280716 Method for treating itching of the vagina |
| 08/28/2001 | US6280714 Lip care composition containing acexamic acid, and uses thereof |
| 08/28/2001 | US6280710 Delivery systems for active ingredients including sunscreen actives and methods of making same |
| 08/28/2001 | US6280705 Kits & systems for ultrasonic imaging |
| 08/28/2001 | CA2322579C Gelling ophthalmic compositions containing xanthan gum |
| 08/28/2001 | CA2217888C Triacetin as a transdermal penetration enhancer |
| 08/28/2001 | CA2190591C Microparticle delivery system |
| 08/28/2001 | CA2178487C Local delivery of fibrinolysis enhancing agents |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001060998A2 Small oligonucleotides with anti-tumor activity |
| 08/23/2001 | WO2001060922A1 Process for the preparation of micronised collagen, and its therapeutic applications |
| 08/23/2001 | WO2001060503A1 Mixing apparatus |
| 08/23/2001 | WO2001060425A1 Biodegradable material |
| 08/23/2001 | WO2001060420A1 A medicinal aerosol formulation |
| 08/23/2001 | WO2001060417A2 Radioactive therapeutic liposomes |
| 08/23/2001 | WO2001060414A2 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | WO2001060410A1 Sustained release preparations of physiologically active compound hardly soluble in water and production process and use of the same |
| 08/23/2001 | WO2001060409A1 Improved paste formulations |
| 08/23/2001 | WO2001060407A2 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis |
| 08/23/2001 | WO2001060402A2 Proteosome influenza vaccine |
| 08/23/2001 | WO2001060394A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
| 08/23/2001 | WO2001060392A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | WO2001060382A1 Micelles |
| 08/23/2001 | WO2001060380A1 A parasiticidal formulation and a method of making this formulation |
| 08/23/2001 | WO2001060377A2 Methods for treatment of lysosomal storage diseases using biphosphonates |
| 08/23/2001 | WO2001060376A1 Male contraceptive formulation comprising norethisterone |
| 08/23/2001 | WO2001060374A1 Use of paullone derivatives for making medicines |
| 08/23/2001 | WO2001060364A1 Method for reducing or eliminating smoking |
| 08/23/2001 | WO2001060353A1 Liquid preparation with improved absorbability |
| 08/23/2001 | WO2001060349A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 08/23/2001 | WO2001060348A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 08/23/2001 | WO2001060341A1 Powder formulation |
| 08/23/2001 | WO2001060340A1 Delivery capsules |
| 08/23/2001 | WO2001060339A2 Method for the preparation of microspheres which contain colloidal systems |
| 08/23/2001 | WO2001060338A1 Drug carrier pellet production process |
| 08/23/2001 | WO2001060337A1 Compositions for topical delivery of a pharmaceutically active agent having reduced oxidation |
| 08/23/2001 | WO2001060336A1 Compositions for topical delivery of a pharmaceutically active agent having reduced skin irritation |
| 08/23/2001 | WO2001060335A2 Delivery systems using preformed biodegradable polymer compositions and methods |
| 08/23/2001 | WO2001060333A1 Delivery system for topical skin care agents |
| 08/23/2001 | WO2001060325A1 Pharmaceutical composition |
| 08/23/2001 | WO2001060278A2 Oral therapeutic delivery appliance |
| 08/23/2001 | WO2001024807A3 Method for calming human beings using personal care compositions |
| 08/23/2001 | WO2001022989A3 Method to enhance healing of sternum after sternotomy |
| 08/23/2001 | WO2001013903A3 Treatment of restless leg syndrome with a combination of clonidine and opioid |
| 08/23/2001 | WO2001013902A3 Combination of active agents, said combination containing clonidine and pramipexol |
| 08/23/2001 | WO2001012159A3 Artificial tear replacement solution |
| 08/23/2001 | WO2000072883A3 Pharmaceutical transdermal compositions |
| 08/23/2001 | US20010016606 A container with an opening that has a closure that can be released to dispense propanethial-s-oxide, which is held in an interior compartment in individual dosages of a strength to induce tearing in a mammalian eye |
| 08/23/2001 | US20010016603 Calcium formate for use as a dietary supplement |
| 08/23/2001 | US20010016593 Multilayer |
| 08/23/2001 | US20010016577 Aqueous liquid containing active ingredient, clay, and a gum; protective coatings; retention; nausea, heartburn, diarrhea; side effect reduction |
| 08/23/2001 | US20010016224 Such as sugarcoating or film coating pharmaceuticals, the material is moved along the bottom and/or along the wall in a centrifugally, tangentially rolling movement with respect to the vertical axis of the container; uniformity |
| 08/23/2001 | US20010016220 Core of dietary fiber surrounded by biologically active subtance such as probiotic microorgansims and a shell forming substance; bioavailability |
| 08/23/2001 | US20010016218 Method for production of arachidonic acid |
| 08/23/2001 | US20010016212 Topical mixture of organic chicken and hen herb, organic ruta herb, unsalted butter and pure beeswax; for various skin disorders such as eczema, dryness, itchiness |
| 08/23/2001 | US20010016210 Drug formulation including polymeric microspheres with high bioadhesive force; improved bioavailability of various drugs such as anticancer agents, antiviral agents, parasiticides, and peptides, antibodies, vaccines, and oligonucleotides |
| 08/23/2001 | US20010016209 Molecular dispersion composition with enhanced bioavailability |
| 08/23/2001 | US20010016208 Chewable tablets containing mannitol and Aspartame |
| 08/23/2001 | US20010016206 For delivery of water insoluble active retinoid agents comprising a vehicle for initially dissolving the active agent, emulsifier and capsule shell formulated to open in the gastrointestinal tract |
| 08/23/2001 | US20010016196 Immunoliposomes that optimize internalization into target cells |
| 08/23/2001 | DE10038110A1 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |
| 08/23/2001 | DE10008128A1 Endoparasiticide composition effective on topical administration, comprises solution of depsipeptide in solvent such as 1,2-isopropylidene-glycerol |
| 08/23/2001 | DE10007203A1 Composition for treating allergic and/or vasomotor rhinitis or allergic conjunctivitis by topical or oral administration, contains synergistic combination of non-sedating antihistamine and leukotriene antagonist |
| 08/23/2001 | DE10005936A1 Creme, insbesondere zur äußeren Anwendung auf der Nasenhaut Cream, especially for external use on the skin of the nose |
| 08/23/2001 | CA2400845A1 Sustained-release preparation of physiologically active compound slightly soluble in water and production process and use of the same |
| 08/23/2001 | CA2400634A1 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | CA2400374A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | CA2400353A1 Method for reducing or eliminating smoking |
| 08/23/2001 | CA2400209A1 Oral therapeutic delivery appliance |
| 08/23/2001 | CA2400178A1 Nail lacquer pharmaceutical composition |
| 08/23/2001 | CA2399822A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
| 08/23/2001 | CA2399807A1 Delivery system for topical skin care agents |
| 08/23/2001 | CA2398945A1 Small oligonucleotides with anti-tumor activity |
| 08/23/2001 | CA2398691A1 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | CA2398068A1 Mixing apparatus |
| 08/23/2001 | CA2398063A1 Male contraceptive formulation comprising norethisterone |
| 08/23/2001 | CA2397560A1 Use of paullone derivatives for making medicines |
| 08/22/2001 | EP1125954A2 Preparation and use of water soluble or water dispersible polyether containing polymers |
| 08/22/2001 | EP1125586A1 Sustained-release particles |
| 08/22/2001 | EP1125578A1 Tape material for transcutaneous absorption |